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Abstract: INTRODUCTION Increased expression of hyperphosphorylated tau and the formation of neu-
rofibrillary tangles are associated with neuronal loss and white matter damage. Using high-resolution ex
vivo diffusion tensor imaging (DTI), we investigated microstructural changes in the white and grey matter
in the P301L mouse model of human tauopathy at 8.5 months of age. For unbiased computational anal-
ysis, we implemented a pipeline for voxel-based analysis (VBA) and atlas-based analysis (ABA) of DTI
mouse brain data. METHODS Hemizygous and homozygous transgenic P301L mice and non-transgenic
littermates were used. DTI data were acquired for generation of fractional anisotropy (FA), mean dif-
fusivity (MD), radial diffusivity (RD), and axial diffusivity (AD) maps. VBA on the entire brain was
performed using SPM8 and the SPM Mouse toolbox. Initially, all DTI maps were coregistered with
the Allen mouse brain atlas to bring them to one common coordinate space. In VBA, coregistered DTI
maps were normalized and smoothed in order to perform two-sample and unpaired t tests with false
discovery rate correction to compare hemizygotes with non-transgenic littermates, homozygotes with
non-transgenic littermates, and hemizygotes with homozygotes on each DTI parameter map. In ABA,
the average values for selected regions of interests were computed with coregistered DTI maps and labels
in Allen mouse brain atlas. Afterwards, a Kruskal-Wallis one-way ANOVA on ranks with a Tukey post
hoc test was executed on the estimated average values. RESULTS With VBA, we found pronounced and
brain-wide spread changes when comparing homozygous, P301L mice with non-transgenic littermates,
which were not seen when comparing hemizygous P301L with non-transgenic animals. Statistical compar-
ison of DTI metrics in selected brain regions by ABA corroborated findings from VBA. FA was found to
be decreased in most brain regions, while MD, RD, and AD were increased in homozygotes compared to
hemizygotes and non-transgenic littermates. DISCUSSION/CONCLUSION High-resolution ex vivo DTI
demonstrated brain-wide microstructural and gene-dose-dependent changes in the P301L mouse model
of human tauopathy. The DTI analysis pipeline may serve for the phenotyping of models of tauopathy
and other brain diseases.
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Abstract
Introduction: Increased expression of hyperphosphorylated 
tau and the formation of neurofibrillary tangles are associ-
ated with neuronal loss and white matter damage. Using 
high-resolution ex vivo diffusion tensor imaging (DTI), we 
investigated microstructural changes in the white and grey 
matter in the P301L mouse model of human tauopathy at 8.5 
months of age. For unbiased computational analysis, we im-
plemented a pipeline for voxel-based analysis (VBA) and at-
las-based analysis (ABA) of DTI mouse brain data. Methods: 
Hemizygous and homozygous transgenic P301L mice and 
non-transgenic littermates were used. DTI data were ac-
quired for generation of fractional anisotropy (FA), mean dif-
fusivity (MD), radial diffusivity (RD), and axial diffusivity (AD) 
maps. VBA on the entire brain was performed using SPM8 
and the SPM Mouse toolbox. Initially, all DTI maps were 
coregistered with the Allen mouse brain atlas to bring them 
to one common coordinate space. In VBA, coregistered DTI 
maps were normalized and smoothed in order to perform 
two-sample and unpaired t tests with false discovery rate 
correction to compare hemizygotes with non-transgenic lit-
termates, homozygotes with non-transgenic littermates, 
and hemizygotes with homozygotes on each DTI parameter 
map. In ABA, the average values for selected regions of inter-
ests were computed with coregistered DTI maps and labels 
in Allen mouse brain atlas. Afterwards, a Kruskal-Wallis one-
way ANOVA on ranks with a Tukey post hoc test was execut-
ed on the estimated average values. Results: With VBA, we 
found pronounced and brain-wide spread changes when 
comparing homozygous, P301L mice with non-transgenic 
littermates, which were not seen when comparing hemizy-
gous P301L with non-transgenic animals. Statistical compar-
ison of DTI metrics in selected brain regions by ABA corrobo-
rated findings from VBA. FA was found to be decreased in 
most brain regions, while MD, RD, and AD were increased in 
homozygotes compared to hemizygotes and non-transgen-
ic littermates. Discussion/Conclusion: High-resolution ex 
vivo DTI demonstrated brain-wide microstructural and 
gene-dose-dependent changes in the P301L mouse model 
of human tauopathy. The DTI analysis pipeline may serve for 
the phenotyping of models of tauopathy and other brain dis-
eases. © 2021 The Author(s).
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Alzheimer’s disease (AD), progressive supranuclear 
palsy, and corticobasal degeneration and frontotemporal 
dementia including frontotemporal dementia with Par-
kinsonism linked to chromosome 17 (FTDP-17) and 
Pick’s disease are characterized by the progressive forma-
tion of neurofibrillary tangles (NFTs) [1, 2]. NFTs are in-
tracellular neuronal lesions composed of insoluble, con-
formationally abnormal, hyperphosphorylated accumu-
lations of tau in neurons and glia [2]. The presence of 
NFTs in the brain triggers a complex cascade of biochem-
ical and cellular processes that result in neurodegenera-
tion and neuronal loss [2]. The occurrence of NFTs cor-
relates well with spatial patterns of neuronal loss and is 
related to the degree of cognitive deficits [3, 4].
Magnetic resonance imaging (MRI) has been used to 
non-invasively characterize tissue changes in the brain 
associated with tau pathology. Structural MRI studies 
have shown that NFT deposition is associated with grey 
matter atrophy that results from neurodegeneration and 
that different tauopathies display distinctive regional pat-
terns of grey matter atrophy [5–8]. In addition, white 
matter changes such as white matter atrophy and the oc-
currence of white matter hyperintensities have been re-
ported [9]. Such observations are indicative of white mat-
ter damage and demyelination caused by axonal tau pa-
thology [10]. Despite their usefulness, structural MRI 
provides little information about the underlying neuro-
degenerative changes in the brain.
Diffusion-weighted imaging is a MRI technique that 
probes the directional diffusivity of water molecules and 
can, thus, yield information about the microstructural 
properties of brain tissue [11–13]. Diffusion imaging data 
are commonly analysed using a tensor model, that is, by 
applying diffusion tensor imaging (DTI) [14]. DTI shows 
sensitivity to axon and myelin pathology, where break-
down of white matter integrity results in measurable dif-
ferences in diffusion of water molecules [15, 16]. DTI has 
been widely used to assess white matter abnormalities re-
lated to tau pathologies [17–23]. A few DTI studies have 
also reported changes in diffusivity in the grey matter [24, 
25]. Importantly, DTI microstructural changes seem to 
precede gross anatomical changes seen on structural MRI 
[24].
Genetic studies show that the development of neuro-
degenerative tauopathies is associated with missense 
mutations in the microtubule-associated tau protein 
(MAPT) [26]. Based on this finding, transgenic mouse 
lines with MAPT mutations gene including P301S [27] 
and P301L [28–31] have been developed. Some models 
have the advantage of tetracycline-controlled transcrip-
tional suppression of tau [31]. Histological studies have 
demonstrated deposition of NFTs pathology, in particu-
lar, in the cortex (CRX) and hippocampus and marked 
atrophy of these areas [27–32]. Behavioural analysis re-
vealed cognitive deficits in learning and motor tasks [30, 
31].
Transgenic mouse models of tauopathy have been 
used in MRI studies [33–38]. Previous DTI studies assess-
ing microstructural changes in rTg4510 mice, which ex-
press transgenic tau P301L mutations driven by a Ca2+/
calmodulin kinase II promoter system [30, 31] in the 
white and grey matter produced conflicting results [33–
36]. Thus, we wished to determine DTI metrics in trans-
genic P301L mice, which express tau under the control of 
the murine Thy 1.2 promoter [28, 29]. In the present 
study, we used ex vivo DTI to assess microstructural 
changes in 8.5-month-old P301L mice in both white and 
grey matter regions. We leveraged the ability of long data 
acquisitions that are possible in ex vivo DTI to achieve a 
high spatial resolution, without suffering from image cor-
ruption due to motion or breathing that are common in 
in vivo DTI [12, 13]. We implemented a pipeline for vox-
el-based analysis (VBA) and atlas-based analysis (ABA) 
for unbiased computational analysis of DTI mouse brain 
data. To test for gene-dose-dependent effects, we assessed 
both hemizygous and homozygous P301L mice and com-
pared them with non-transgenic littermates. We hypoth-
esized that effects on DTI microstructural parameters 
would be stronger in homozygotes than in hemizygotes 




P301L mice, expressing the human 4 repeat tau isoform un-
der the control of the murine Thy 1.2 promoter, were back-
crossed with C57BL/6 mice for >20 generations and maintained 
on a C57BL/6 background (B6.Dg-Tg [Thy1.2-TauP301L] 
183Nitsch) [28, 29]. Hemizygous P301L mice were used for 
breeding to generate homozygous P301L mice. Hemizygous 
(n = 8; 5 females/3 males) and homozygous (n = 8; 5 females/3 
males) P301L mice of 8.5 months of age and age-matched non-
transgenic littermates (n = 8; 2 females/6 males) were used. An-
imals were housed in ventilated cages inside a temperature-con-
trolled room, under a 12-h dark/light cycle. Each cage housed up 
to 5 mice. Paper tissue and red Tecniplast mouse house® (Tecni-
plast, Milan, Italy) shelters were placed in cages as environmen-
tal enrichments. Pelleted food (3437PXL15, CARGILL) and wa-
ter were provided ad libitum.
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Magnetic Resonance Imaging
Mice were intracardially perfused under deep anaesthesia of 
ketamine/xylazine/acepromazine maleate (75/10/2 mg/kg body 
weight, i.p. bolus injection) with 10 mL ice-cold 0.1 M PBS (pH 
7.4) and 4% paraformaldehyde in 0.1 M PBS. Heads were re-
moved and post-fixed in paraformaldehyde solution for 6 days. 
Thereafter, samples were stored in 0.1 M PBS (pH 7.4) at 4°C 
until measurements. Brains were not removed from the skull, 
which has been shown previously to preserve cortical and central 
brain structure [35]. The heads were placed in a 15 mL centrifuge 
tube filled with perfluoropolyether (Fomblin Y, LVAC 16/6, av-
erage molecular weight 2,700, Sigma-Aldrich, St. Louis, MO, 
USA). Data were acquired on a small-animal MRI system (Bio-
Spec 94/30 animal MRI system, Bruker Corporation) at 400 MHz 
and equipped with a BGA 12AS HP gradient system with a max-
imum gradient strength of 400 mT/m and minimum rise time of 
70 μs. A cryogenic 2 × 2 channel radiofrequency surface coil 
probe (overall coil size 20 × 27 mm2, Bruker BioSpin AG, Fäl-
landen, Switzerland) with the coil system operating at 30 K 
(Bruker BioSpin AG, Fällanden, Switzerland) was used in com-
bination with a circularly polarized 86-mm volume resonator for 
transmission.
DTI was acquired with 3D multishot echo-planar imaging se-
quence (4 shots) with a field of view of 18 × 12 × 9 mm and a ma-
trix dimension of 180 × 120 × 90, resulting in a nominal voxel 
resolution of 100 × 100 × 100 μm. The following imaging param-
eters were chosen: a repetition time of 1,500 ms, an echo time of 
28 ms, no averaging, 5 volumes acquired with a b-values of 0 (A0), 
and a b-value of 4,000 s/mm2 along 60 diffusion encoding direc-
tions. A global and MAPSHIM protocol with a field map (default 
settings) was used for shimming. The total acquisition time per 
brain was 9 h 45 min.
Image Processing
Image processing was performed with the Nora medical imag-
ing platform (http://www.nora-imaging.com/; University Medical 
Center Freiburg, Germany) [39, 40]. All the data were first up-
loaded to the platform and automatically converted into NIFTi 
format. Diffusion tensors were estimated using DTI&Fibertools 
(https://www.uniklinik-freiburg.de/mr-en/research-groups/diff-
perf/fibertools.html), and on this basis, fractional anisotropy (FA), 
mean diffusivity (MD), radial diffusivity (RD), and axial diffusiv-
ity (AD) maps were computed. To normalize images to an atlas 
space, SPM8 (Wellcome Trust Centre for Neuroimaging, UCL, 
UK) together with the SPM Mouse toolbox (University of Oxford, 
UK) were used. For each scan, the b0 image was normalized to the 
mouse atlas space using the SPM normalize and segment tool. Fur-
ther, the Allen mouse brain atlas (http://mouse.brain-map.org/
static/atlas) was also non-linearly registered to the atlas space to 
enable the VBA and ABA. Maximization of the mutual informa-
tion was used for image registration. Mutual information or rela-
tive entropy is a widely used similarity measure in medical image 
registration [41]. As we maximize the mutual information, the in-
formation from the combined images is minimized compared to 2 
separate images. All considered microstructural maps (FA, MD, 
RD, and AD) were finally warped to atlas space for VBA and ABA. 
To evaluate if the registration was done properly, we visually in-
spected images after registration with SPM, overlaying one image 
on the top of another. Registration for VBA and ABA was found 
to be done properly.
Voxel-Based Analysis
VBA on the entire brain was performed using SPM8. In addi-
tion, the SPM Mouse toolbox (University of Oxford, UK) was used 
because it extends the SPM functionality to the animal brains. All 
normalized images were smoothed (0.1 × 0.1 × 0.1 mm2 Gaussian). 
Besides, the average maps of each parameter for every subgroup 
were generated to visualize the estimated t-values on it. In total, 3 
unpaired two-sample t tests were executed, including the compari-
sons of hemizygotes versus homozygotes, hemizygotes versus non-
transgenic littermates, and homozygotes versus non-transgenic lit-
termates. Statistical maps were thresholded with a significance lev-
el of p < 0.001 and then, were corrected using false discovery rate. 
Results were superimposed on FA, MD, RD, and AD maps.
Atlas-Based Analysis
Allen mouse brain atlas was overlaid on each normalized im-
age. The atlas contains 670 labelled regions. In order to limit the 
number of candidate regions for the examination, we selected re-
gion of interests (ROIs) for the anterior commissure (AC), corpus 
callosum (CC), cerebral peduncle (CPD), cortex (CRX), hippo-
campal region (HPR), subiculum (SUB), and thalamus (TH). ROIs 
were slightly eroded to avoid partial volume effects. Then, the av-
erage values of each ROI from the atlas were computed. ROI data 
were tested using the Kolmogorov-Smirnov test, which showed 
that all data were not normally distributed. Variance homogeneity 
was tested using the Levene test which showed regions with and 
without homogeneous variance. Thus, a Kruskal-Wallis one-way 
ANOVA on ranks was used to determine differences between AD, 
MD, RD, and FA in these ROIs. A Tukey post hoc test was used for 
pairwise multiple comparisons between hemizygotes versus ho-
mozygotes, hemizygotes versus non-transgenic littermates, and 
homozygotes versus non-transgenic littermates. We used p < 0.05, 
p < 0.01, p < 0.001, and p < 0.0001 as our significance levels. All 
computations were done using Python version 3.5.0.
Results
The reconstructed data are available in the Zenodo re-
pository (DOI: 10.5281/zenodo.4005562). We also made 
the code for VBA and ABA available (https://github.com/
aidanamv/ABA-pipeline).
We examined ex vivo DTI metrics of the brains of 
hemizygous and homozygous P301L mice at 8.5 months 
of age. Resulting maps of the FA, MD, RD, and AD are 
shown in Figure 1 and in different views in online supple-
mentary Figures 1–4 (for all online suppl. material, see 
www.karger.com/doi/10.1159/000515754). The high-
resolution FA maps show clearly white matter structures 
that are highly anisotropic, like the CC and the AC and 
hippocampal commissure (HC).
VBA Reveals Gene-Dose-Dependent Effects on DTI 
Metrics
VBA was performed to compare differences in FA, 





dose-dependent effects. Firstly, we compared hemizy-
gous P301L mice with non-transgenic littermates, but 
no different changes between the 2 groups were ob-
served. Secondly, we compared homozygous P301L 
mice with non-transgenic littermates (Fig. 2). The co-
lour gradient represents the magnitude of significant 
differences between groups (unpaired two-sample t test 
with clusterwise FDR correction). Pronounced changes 
in the white matter such as the CC and HC were ob-
served for all DTI metrics. In addition, group differenc-
es were also detected in grey matter structures such as 
the CRX, hippocampus, and TH. Thirdly, we compared 
hemizygotes with homozygotes (Fig. 3). Group differ-
ences were seen in both the grey and white matter in all 
DTI metrics in the HC only.
ABA Reveals Grey and White Matter Alterations 
Related to Tau Pathology
Results of ABA are shown in Table 1 and Figure 4. Sta-
tistical analysis was performed in 3 white matter regions 
(AC, CC, and CPD) and 4 grey matter regions (HPRs, 
CRX, SUB, and TH).
Fractional Anisotropy
In the AC, there was no difference in FA between 
groups observed. In the CC, HPR, SUB, and TH, FA val-
ues were significantly decreased in homozygous P301L 
mice compared to hemizygous transgenic mice and com-
pared to non-transgenic littermates. In the CPD and 
CRX, FA values were found reduced in hemizygote P301L 
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0 1 0 5 × 10–4 0 3 × 10–4 0 4 × 10–4
Fig. 1. Representative coronal FA, MD, RD, and AD maps of 
8.5-month-old non-transgenic littermates, hemizygous, and ho-
mozygous P301L mice. Shown are views at approximately −1.8 
mm from bregma. AD, RD, and MD values are in units of ×10−4 
mm2/s. FA, fractional anisotropy; MD, mean diffusivity; RD, ra-
dial diffusivity; AD, axial diffusivity.
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Mean Diffusivity
MD values were significantly increased in the AC, CC, 
CPD, CRX, HPR, and TH in homozygote P301L mice com-
pared to non-transgenic and hemizygous littermates. For 
the SUB, values were higher in homozygotes than in non-
transgenic littermates. In the CPD, MD values were higher 
in hemizygous P301L mice and non-transgenic controls.
Radial Diffusivity
RD values were significantly increased in the AC, CC, 
CPD, HPR, SUB, and TH in homozygous P310L mice 
compared to hemizygotes and non-transgenic litter-
mates. In the CRX, RD values were found significantly 
increased in homozygous P301L mice compared to hemi-








































Fig. 2. VBA (t values overlaid on mouse brain template) comparing 
homozygous P301L mice with non-transgenic littermates (un-
paired two-sample t test p < 0.001, clusterwise FDR correction). 
Changes in DTI metrics were observed across the brain, in both 
grey and white matter areas. VBA, voxel-based analysis; FDR, false 
discovery rate; DTI, diffusion tensor imaging; FA, fractional an-






increased in hemizygous P301L mice compared to non-
transgenic littermates.
Axial Diffusivity
AD values were significantly increased in the AC, CC, 
CPD, CRX, HPR, and TH in homozygous P301L mice 
compared to non-transgenic littermates. In the AC, CPD, 
CRX, HPR, and TH, AD values were also significantly 
higher in homozygous P301L mice than in hemizygous 
mice. No differences were observed between hemizygous 









































Fig. 3. Grade of tau gene expression determines severity of DT al-
terations. VBA (t values overlaid on mouse brain template) com-
paring hemizygous with homozygous P301L mice (p < 0.001, clus-
terwise FDR correction). Changes in DTI metrics were observed 
across the brain. VBA, voxel-based analysis; FDR, false discovery 
rate; DTI, diffusion tensor imaging; FA, fractional anisotropy; MD, 
mean diffusivity; RD, radial diffusivity; AD, axial diffusivity.
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Discussion/Conclusion
DTI has been previously used in patient studies to as-
sess microstructural changes related to tau pathologies 
[17–25]. Application of DTI to animal models of tauopa-
thy may be useful for validation and mechanistic studies 
and monitoring of tau-targeted therapies. Previously, 
DTI has been applied to characterize brain tissue changes 
in the rTg4510 strain [33–36] but produced varied results. 
Thus, we aimed to investigate the effects of tau pathology 
Anterior commissure (AC) Corpus callosum (CC) Cortex (CRX) Thalamus (TH)














































































Fig. 4. Gene-dose-dependent effects on DTI metrics. ABA of se-
lected brain regions in non-transgenic littermates, hemizygous, 
and homozygous P301L mice. Regions analysed where the AC, CC, 
CPD, CRX, HPR, SUB, and TH. Data are represented in box plots. 
Centre lines show the median; box limits indicate the first and 
third quartile; whiskers show the minimum and maximum. One-
way ANOVA. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 
0.0001. DTI, diffusion tensor imaging; ABA, atlas-based analysis; 
AC, anterior commissure; CC, corpus callosum; CPD, cerebral pe-
duncle; CRX, cerebral cortex; HPR, hippocampal region; SUB, su-
biculum; TH, thalamus; FA, fractional anisotropy; MD, mean dif-





on DTI metrics in the P301L models of human tauopathy. 
We acquired ex vivo DTI data in 8.5-month-old hemizy-
gous and homozygous P301L mice and age-matched 
non-transgenic littermates. VBA revealed microstructur-
al changes in both white and grey matter regions in ho-
mozygotes but not in hemizygotes P301L mice. ABA 
showed that decreased FA in most brain regions, while 
MD, RD, and AD were increased in homozygous P301L 
mice compared to hemizygous and non-transgenic litter-
mates.
In contrast to previous studies where DTI in mice was 
performed in vivo [33–36], we performed ex vivo DTI. 
Compared to the in vivo setting, ex vivo DTI has the ad-
vantage that it is not hampered by motion artefacts, for 
example, breathing. It also allows for prolonged scanning 
times. We acquired 3D data with 100 μm isotropic resolu-
tion in 9 h 45 min. We measured complete head samples, 
which preserve the structural integrity of the brains [35] 
in a high-field small-bore magnet with cryogenic radio-
frequency coils [42] to obtain diffusion data with suffi-












AC FA 0.56±0.07 0.56±0.08 0.50±0.03
MD 0.14±0.01 0.15±0.03 0.19±0.02*, #
RD 0.06±0.02 0.06±0.02 0.11±0.01*, #
AD 0.18±0.02 0.19±0.03 0.23±0.02*, #
CC FA 0.58±0.05 0.58±0.05 0.51±0.02*, #
MD 0.14±0.02 0.15±0.03 0.18±0.01*, #
RD 0.06±0.01 0.06±0.02 0.10±0.01*, #
AD 0.18±0.01 0.19±0.03 0.22±0.02*
CPD FA 0.55±0.05 0.61±0.07 0.48±0.06#
MD 0.18±0.02 0.16±0.03* 0.21±0.02*, #
RD 0.08±0.01 0.05±0.03* 0.12±0.02*, #
AD 0.23±0.00 0.21±0.02 0.25±0.01*, #
CRX FA 0.28±0.02 0.29±0.02 0.26±0.02#
MD 0.19±0.01 0.21±0.05 0.25±0.02*, #
RD 0.15±0.01 0.15±0.04 0.21±0.02#
AD 0.22±0.00 0.24±0.05 0.28±0.02*, #
HPR FA 0.29±0.02 0.29±0.03 0.26±0.02*, #
MD 0.22±0.01 0.23±0.04 0.27±0.01*, #
RD 0.17±0.01 0.18±0.04 0.23±0.02*, #
AD 0.25±0.00 0.26±0.04 0.30±0.02*, #
SUB FA 0.28±0.03 0.28±0.00 0.23±0.01*, #
MD 0.19±0.01 0.20±0.05 0.23±0.0202*
RD 0.10±0.01 0.12±0.04 0.16±0.02*, #
AD 0.22±0.01 0.23±0.04 0.26±0.02
TH FA 0.34±0.04 0.34±0.03 0.28±0.03*, #
MD 0.16±0.01 0.17±0.04 0.21±0.01*, #
RD 0.12±0.01 0.14±0.03 0.13±0.02*, #
AD 0.19±0.01 0.20±0.04 0.24±0.02*, #
Mean ± SD; AD, RD, and MD values are in units of ×10−3 mm2/s. DTI, diffusion tensor imaging; ABA, atlas-
based analysis; AC, anterior commissure; CC, corpus callosum; CPD, cerebral peduncle; CRX, cerebral cortex; 
HPR, hippocampal region; SUB, subiculum; TH, thalamus; MD, mean diffusivity; RD, radial diffusivity; AD, axial 
diffusivity. * p < 0.05 versus non-transgenic littermates. # p < 0.05 versus hemizygous. One-way ANOVA.
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cient signal-to-noise ratio for automated VBA and ABA 
analyses. Nevertheless, ex vivo DTI requires chemical fix-
ation with formaldehyde to preserve the tissue and the 
procedure alters the macroscopic and microscopic prop-
erties of the tissue. For example, a study by Ma et al. [43] 
has shown that most of the white structures demonstrat-
ed significantly larger ex vivo volumes after fixation than 
in vivo volumes (i.e., internal capsule and fimbria) except 
for the smallest white matter structure (e.g., AC), which 
was significantly smaller ex vivo. Conversely, grey matter 
structures (e.g., neocortex, TH, and hippocampus) de-
creased in volume. Fixation does alter the magnitude of 
water diffusion in the tissue, but measures of the direc-
tionality of diffusion are less affected [44–46]. The subse-
quent placement of samples in PBS removed excess fixa-
tive and, while it does not reverse the chemical effects of 
fixation, it has been shown to partially restore diffusivity 
of the tissue [46]. As samples are equally treated, the vol-
ume changes induced by fixation do not hamper ad-
vanced, unbiased computational approaches and allow 
detection of anatomical phenotypes in transgenic ani-
mals. The reduced diffusivity of fixed tissue requires 
strong gradients for strong diffusion weighting. These are 
commonly available in small-bore animal scanners. We 
used a b-value of 4,000 s/mm2, as recommended for ex 
vivo DTI [47].
Previous studies have used ROI analysis [33–36], while 
we opted for VBA and ABA for statistical analysis of DTI 
data. For ROI analysis, selected areas are manually drawn, 
which is more time consuming, requires a priori anatom-
ical localization, and is prone to bias [48]. Moreover, in 
many neurodegenerative diseases, microstructural 
changes occur across the whole brain, and conventional 
ROI analysis may miss to detect changes in areas that are 
not selected [49]. VBA has been widely used in structural 
MRI as an unbiased approach to assess morphological 
changes of tissue [43, 50]. Voxel-by-voxel statistical com-
parison is performed once all brain images are normal-
ized to a template space, with the assumption that each 
individual voxel represents the same anatomical location 
of the brain [49, 51, 52].
The spatial normalization of the brains in VBA was 
based on scalar image-based registration, incorporating 
12-parameter affine transformation and diffeomorphic 
mapping, which is essentially done to match internal 
brain structures to the template. One may apply a low-
pass filter to smooth normalized images; however, the 
fact, if the particular location is the same voxel in other 
images, is still questionable due to the potential atrophy 
in the brain [51]. Smoothing in DTI is also challenging 
due to thin tracts of white matter and heterogeneity of the 
FA maps. Nevertheless, this method is still in use in bio-
medical imaging due to its simplicity [50]. Besides, its sta-
tistical power is poor due to the high level of noise.
With VBA, we found marked changes when compar-
ing homozygous P301L mice with non-transgenic litter-
mates, while we did not observe differences between 
hemizygous transgenic mice and non-transgenic litter-
mates. The comparisons demonstrated that changes in 
DTI metrics are gene-dose dependent, where mice with 
the stronger tau transgene expression (i.e., homozygous 
P301L mice) show the phenotype. This finding is in line 
with the results of the ABA where differences in DTI met-
rics were found between homozygous P301L mice and 
homozygous and non-transgenic littermates. It may be 
speculated that use of larger group sizes or animals of old-
er ages might have also revealed differences between 
hemizygous P301L and non-transgenic animals, as the 
hemizygous mice also have tau pathology.
While the VBA revealed areas of significant changes in 
DTI metrics, it does not inform about the direction of the 
changes. Thus, we used ABA to obtain regional values of 
FA, MD, RD, and AD. ABA analysis is based on auto-
matic segmentation of brain regions defined in the atlas 
after normalization [51–54]. This provides high sensitiv-
ity to small and widely distributed changes, but it fails 
when the regions are not within the anatomical boundar-
ies of the predefined atlas [54]. Results from ABA re-
vealed a decrease in FA and increased MD, RD, and AD 
values in the CC compared to non-transgenic littermates, 
while other white matter regions were unchanged. An 
earlier study by Sahara et al. reported age-dependent 
changes in DTI metrics in rTg4510 mice [33]. A decrease 
in FA values was noted in the CC, AC, internal capsule, 
splenium, and fimbria of 8-month-old rTg4510 mice. RD 
was found increased in the CC, splenium, and fimbria, 
while MD and AD were unchanged. A study by Colgan et 
al. [36] found lower FA values and higher MD in the CC 
of 8.5-month-old rTg4510 mice than in non-transgenic 
littermates. A study by Wells et al. reported increased RD 
values in the CC in rTg4510, while FA, MD, and AD were 
not different from non-transgenic littermates [34].
DTI is also increasingly used to assess microstructural 
changes in the grey matter [55]. In our study, we found 
decreased FA values and increased MD, RD, and AD val-
ues in the HPRs, CRX, and TH in homozygous P301L 
mice compared to non-transgenic controls. A previous 
study by Wells et al. [34] reported increased FA and MD 
in the CRX and hippocampus of rTg4510 mice. In the TH, 





changed. A study by Holmes et al. [35] reported increased 
FA and MD in the CRX and hippocampus of rTg4510 
mice. In the TH, FA was increased, while MD was not dif-
ferent. In a study by Colgan et al. [36], MD was increased 
in the hippocampus and CRX. FA was higher in the hip-
pocampus but was not different in the CRX. No change 
in FA and MD has been observed in the TH.
Differences in DTI metrics in cross-sectional studies in 
transgenic mouse models of tauopathy based on MAPT 
mutations may arise due to the use of different strains, that 
is, the type of tau mutation, promoter of transgene expres-
sion, transgene expression levels, genetic background, and 
housing conditions [56], which are known to affect the 
phenotype. Furthermore, methodological differences in 
DTI data acquisition (in vivo vs. ex vivo and sequence pa-
rameters) and different analysis methods (ROI, VBA, ABA 
etc.) may contribute to the observed differences in studies. 
We made FA, MD, RD, and AD maps and analysis code 
publicly available, which enable other groups to perform 
an independent analysis with our data, to validate the code, 
and to enable of image-based meta-analysis. Finding con-
verging patterns of microstructural changes or identifying 
different phenotypes between different tau mouse models 
compared to clinical studies would increase the transla-
tional value of preclinical DTI studies. In this regard, the 
observed pattern of decreased FA and increased MD, RD, 
and AD values in P301L mice in the current study are in 
good agreement with DTI changes observed in human 
tauopathies such as progressive supranuclear palsy [21], 
frontotemporal dementia [22], mild cognitive impairment 
[24], and Alzheimer`s disease [18, 25].
Effects of tauopathy on DTI metrics in the grey and 
white matter are complex and may involve axonal dam-
age, myelin injury, neuronal degeneration, and gliosis, 
which all have been found in tauopathies [17, 18, 23, 25, 
28, 29, 33, 38, 57]. The interpretation of changes in the 
measured diffusion tensor is thus awaiting histological 
determination. Furthermore, future studies may seek to 
examine microstructural changes in vivo in a longitudi-
nally designed study. For example, it would be important 
to determine the onset of changes in DTI and how this is 
related to gross anatomical changes and cognitive func-
tion. Studies in patients with mild cognitive impairment 
have shown that changes in DTI metrics in the hippocam-
pus, a region involved in working memory formation can 
predict cognitive decline and constitute a more sensitive 
predictor than changes in hippocampal volume [24]. Giv-
en the limitations of DTI, more advanced models for re-
construction diffusion MRI data may be explored [12, 36, 
58].
In summary, ex vivo DTI demonstrated brain-wide 
and gene-dose-dependent microstructural changes in the 
P301L mouse model of human tauopathy, similar to what 
has been observed in patients with tauopathies. The DTI 
analysis pipeline may serve for the phenotyping of models 
of tauopathy and other brain diseases.
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